Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | FADS1 | O60427 | 3/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.30 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.30 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.30 |
| ▸ | CACNA1I | Q9P0X4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5751613 | 0.80 | KCNN4 (0.39) | KCNN4MAOB | |
| SCHEMBL5751187 | 0.76 | EGLN2 (0.35) | KCNN4MAOBFADS1EPHX1CACNA1G | |
| SCHEMBL5752464 | 0.75 | KCNN4 (0.33) | KCNN4MAOB | |
| SCHEMBL5754320 | 0.73 | UBE2M (0.35) | KCNN4MAOBFADS1 | |
| SCHEMBL5752580 | 0.72 | FADS1 (0.44) | FADS1 | |
| SCHEMBL5755612 | 0.72 | KCNN4 (0.35) | KCNN4MAOBFADS1 | |
| SCHEMBL5751232 | 0.71 | GRM5 (0.35) | SLC6A4 | |
| SCHEMBL5752903 | 0.71 | KCNN4 (0.35) | KCNN4MAOBFADS1EPHX1 | |
| SCHEMBL5750810 | 0.71 | KCNN4 (0.33) | KCNN4MAOBFADS1EPHX1 | |
| SCHEMBL5752417 | 0.70 | KCNN4 (0.33) | KCNN4MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6982348-B2 | Aminoethanol derivatives | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2006-01-03 | — | — | US | disclosed |
| US-20040127574-A1 | Aminoethanol derivatives | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-07-01 | — | — | US | disclosed |
| EP-1362846-A1 | AMINOETHANOL DERIVATIVES | Takeda Chemical Industries, Ltd. (JP) | 2003-11-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040127574-A1 | Aminoethanol derivatives | CETP, LCAT, MTTP | KCNN4 4807/4885MAOB 3565/4885FADS1 245/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.